The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
1999
DOI: 10.1016/s0161-6420(99)90485-2
|View full text |Cite
|
Sign up to set email alerts
|

The importance of fluorescein angiography in planning laser treatment of diabetic macular edema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0
2

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(26 citation statements)
references
References 9 publications
0
24
0
2
Order By: Relevance
“…One study, reporting the use of FA in planning laser treatment for DME, found that FA only improved treatment accuracy by 49% to 55% 460 , by significantly improving the treatment accuracy of only one of the four retinal specialists studied 460 . The authors suggest that FA may improve treatment-planning accuracy by reducing either over-treatment or under-treatment, and may help clinicians identify ischaemic areas, for which ETDRS guidelines mandate treatment 461 .…”
Section: Recommendations For Routine Fa In Managing Drmentioning
confidence: 99%
“…One study, reporting the use of FA in planning laser treatment for DME, found that FA only improved treatment accuracy by 49% to 55% 460 , by significantly improving the treatment accuracy of only one of the four retinal specialists studied 460 . The authors suggest that FA may improve treatment-planning accuracy by reducing either over-treatment or under-treatment, and may help clinicians identify ischaemic areas, for which ETDRS guidelines mandate treatment 461 .…”
Section: Recommendations For Routine Fa In Managing Drmentioning
confidence: 99%
“…Intravenous (IV) fluorescein angiography (FA) is the clinical gold standard for assessing retinal vasculature, revealing the extent of disease and response to treatment [1]. Despite its utility, the IV injection of fluorescein dye is considered invasive, and has been reported to cause rare but potentially severe systemic adverse reactions [2][3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…A randomized controlled trial to conclusively demonstrate visual benefit would be prohibitively expensive. 6 Could other noninvasive methods of assessing macular morphology such as optical coherence tomography be used to target laser treatments in the early stages of the disease? At present, UK audit standards for diabetic maculopathy treatment require assessment of waiting times and access to treatment but not of the visual outcome.…”
Section: Commentmentioning
confidence: 99%